Literature DB >> 29554250

Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms.

G F Dall1,2,3, S-T J Tsang2,3,4, P J Gwynne2, S P MacKenzie4, A H R W Simpson3, S J Breusch4, M P Gallagher2.   

Abstract

Objectives: To evaluate putative anti-staphylococcal biofilm antibiotic combinations used in the management of periprosthetic joint infections (PJIs).
Methods: Using the dissolvable bead biofilm assay, the minimum biofilm eradication concentration (MBEC) was determined for the most commonly used antimicrobial agents and combination regimens against staphylococcal PJIs. The established fractional inhibitory concentration (FIC) index was modified to create the fractional biofilm eradication concentration (FBEC) index to evaluate synergism or antagonism between antibiotics.
Results: Only gentamicin (MBEC 64 mg/L) and daptomycin (MBEC 64 mg/L) were observed to be effective antistaphylococcal agents at clinically achievable concentrations. Supplementation of gentamicin with daptomycin, vancomycin or ciprofloxacin resulted in a similar or lower MBEC than gentamicin alone (FBEC index 0.25-2). Conversely, when rifampicin, clindamycin or linezolid was added to gentamicin, there was an increase in the MBEC of gentamicin relative to its use as a monotherapy (FBEC index 8-32). Conclusions: This study found that gentamicin and daptomycin were the only effective single-agent antibiotics against established Staphylococcus biofilms. Interestingly the addition of a bacteriostatic antibiotic was found to antagonize the ability of gentamicin to eradicate Staphylococcus biofilms.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29554250     DOI: 10.1093/jac/dky087

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  Estimation of Minimum Biofilm Eradication Concentration (MBEC) on In Vivo Biofilm on Orthopedic Implants in a Rodent Femoral Infection Model.

Authors:  Yu Okae; Kohei Nishitani; Akio Sakamoto; Toshiyuki Kawai; Takuya Tomizawa; Motoo Saito; Yutaka Kuroda; Shuichi Matsuda
Journal:  Front Cell Infect Microbiol       Date:  2022-07-01       Impact factor: 6.073

2.  Vancomycin elution from a biphasic ceramic bone substitute.

Authors:  M Stravinskas; M Nilsson; A Vitkauskiene; S Tarasevicius; L Lidgren
Journal:  Bone Joint Res       Date:  2019-03-02       Impact factor: 5.853

Review 3.  Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions.

Authors:  Nigare Raheem; Suzana K Straus
Journal:  Front Microbiol       Date:  2019-12-12       Impact factor: 5.640

Review 4.  Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future.

Authors:  Kun Xiang; John N Catanzaro; Claude Elayi; Zerelda Esquer Garrigos; Muhammad R Sohail
Journal:  Cureus       Date:  2021-02-02

5.  In-vitro model for bacterial growth inhibition of compartmentalized infection treated by an ultra-high concentration of antibiotics.

Authors:  Moris Topaz; Abed Athamna; Itamar Ashkenazi; Baruch Shpitz; Sarit Freimann
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

6.  The tale of microencapsulated rifampicin: is it useful for the treatment of periprosthetic joint infection?

Authors:  Irene Isabel López-Torres; Javier Vaquero-Martín; Ana-Isabel Torres-Suárez; Federico Navarro-García; Ana-Isabel Fraguas-Sánchez; Víctor Estuardo León-Román; Pablo Sanz-Ruíz
Journal:  Int Orthop       Date:  2022-01-06       Impact factor: 3.075

7.  MBEC Versus MBIC: the Lack of Differentiation between Biofilm Reducing and Inhibitory Effects as a Current Problem in Biofilm Methodology.

Authors:  Lara Thieme; Anita Hartung; Kristina Tramm; Mareike Klinger-Strobel; Klaus D Jandt; Oliwia Makarewicz; Mathias W Pletz
Journal:  Biol Proced Online       Date:  2019-09-13       Impact factor: 3.244

8.  A sophisticated antibiotic-loading protocol in articulating cement spacers for the treatment of prosthetic joint infection: A retrospective cohort study.

Authors:  Chuang Yang; Jin Wang; Zhifei Yin; Qiaojie Wang; Xianlong Zhang; Yao Jiang; Hao Shen
Journal:  Bone Joint Res       Date:  2019-12-03       Impact factor: 5.853

9.  Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms.

Authors:  Lei Wang; Mariagrazia Di Luca; Tamta Tkhilaishvili; Andrej Trampuz; Mercedes Gonzalez Moreno
Journal:  Front Microbiol       Date:  2019-11-06       Impact factor: 5.640

10.  Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular-matrix envelope.

Authors:  M Rizwan Sohail; Zerelda Esquer Garrigos; Claude S Elayi; Kun Xiang; John N Catanzaro
Journal:  Pacing Clin Electrophysiol       Date:  2020-03-05       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.